PROTONIX ®

Week 8

PROTONIX Heals Erosive Esophagitis

Percent Healed

66%

83.5%

92.6%

39.7%

(n=153)

(n=158)

(n=163)

(n=68)

• Oral Launched in May 2000

• I.V. Approved March 2001

• sNDA Submitted 2Q00 for Maintenance of Healing of Erosive Esophagitis

• Sales at Year-End 2000 Were $145M; 1Q 2001 Sales were $160M

First Once-a-day PPI Available in Both Oral and I.V. Formulations

Previous slide

Next slide

Back to first slide

View graphic version